There were 12 unique analyses with significantly high expression of CXCL11 in breast cancer and 12 unique analyses in colon cancer, and 16 unique analyses with significantly low expression of CXCL12 in breast cancer, and 3 unique analyses with significantly low expression in pancreatic cancer. This evidence concerns the gene CXCL12 and familial pancreatic carcinoma.